Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 2,245.36 | 1,701.61 | 1,675.36 | 1,288.35 |
| Operating Revenue | - | 2,245.36 | 1,701.61 | 1,675.36 | 1,288.35 |
| Cost Of Revenue | - | 907.56 | 835.02 | 987.29 | 1,265.68 |
| Gross Profit | - | 1,337.80 | 866.58 | 688.07 | 22.68 |
| Operating Expense | - | 231.81 | 147.84 | 216.89 | 293.59 |
| Selling General And Administration | - | 100.86 | 99.53 | 100.16 | 76.12 |
| Total Expenses | - | 1,139.36 | 982.87 | 1,204.18 | 1,559.26 |
| Operating Income | - | 1,105.99 | 718.74 | 471.18 | -270.91 |
| EBITDA | - | 968.85 | 930.52 | 894.42 | 176.26 |
| Normalized EBITDA | - | 1,622.43 | 1,165.43 | 931.69 | 298.15 |
| EBIT | - | 460.19 | 475.67 | 428.94 | -388.40 |
| Interest Income | - | 15.46 | 19.46 | 24.41 | 30.83 |
| Interest Expense | - | 123.12 | 103.94 | 79.13 | 246.18 |
| Net Interest Income | - | -118.07 | -94.40 | -63.42 | -223.24 |
| Other Non Operating Income Expenses | - | 2.72 | -17.70 | -20.67 | -18.54 |
| Other Income Expense | - | -650.86 | -252.60 | -57.94 | -140.43 |
| Interest Income Non Operating | - | 15.46 | 19.46 | 24.41 | 30.83 |
| Interest Expense Non Operating | - | 123.12 | 103.94 | 79.13 | 246.18 |
| Net Non Operating Interest Income Expense | - | -118.07 | -94.40 | -63.42 | -223.24 |
| Pretax Income | - | 337.07 | 371.74 | 349.81 | -634.58 |
| Tax Provision | - | 110.52 | 158.22 | 159.96 | 65.20 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -214.29 | -49.33 | -7.83 | -25.60 |
| Net Income Continuous Operations | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Net Income From Continuing And Discontinued Operation | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Net Income From Continuing Operation Net Minority Interest | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Net Income | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Net Income Common Stockholders | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Net Income Including Noncontrolling Interests | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Normalized Income | - | 665.84 | 399.10 | 219.30 | -603.49 |
| Diluted NI Availto Com Stockholders | - | 226.55 | 213.52 | 189.85 | -699.79 |
| Basic Average Shares | - | 455.35 | 459.64 | 470.84 | 477.59 |
| Diluted Average Shares | - | 474.86 | 481.07 | 476.69 | 477.59 |
| Reconciled Depreciation | - | 508.66 | 454.85 | 465.48 | 564.66 |
| Reconciled Cost Of Revenue | - | 907.56 | 835.02 | 987.29 | 1,265.68 |
| Total Unusual Items | - | -653.58 | -234.91 | -37.27 | -121.89 |
| Total Unusual Items Excluding Goodwill | - | -653.58 | -234.91 | -37.27 | -121.89 |
| Special Income Charges | - | -392.69 | -223.78 | -25.17 | -175.56 |
| Other Special Charges | - | -6.81 | 1.50 | 25.17 | 0.20 |
| Impairment Of Capital Assets | - | 449.97 | 222.28 | 0 | 177.56 |
| Restructuring And Mergern Acquisition | 2.58 | 0 | - | - | - |
| Gain On Sale Of Security | - | -260.89 | -11.13 | -12.10 | 53.66 |
| General And Administrative Expense | - | 100.86 | 99.53 | 100.16 | 76.12 |
| Other Gand A | - | 100.86 | 99.53 | 100.16 | 76.12 |
| Gain On Sale Of Ppe | - | 50.47 | 0 | 0 | 2.20 |
| Insurance And Claims | - | 6.24 | 0 | - | - |
| Total Other Finance Cost | - | 10.40 | 9.92 | 8.71 | 7.89 |
| Other Operating Expenses | - | 130.95 | 48.31 | 116.74 | 217.47 |
